This suggests that a vicious cycle between α-syn and NRF2 inhibition may be a key mechanism driving the initiation and progression of PD, offering a novel, currently underexplored target for preventing disease onset and progression (Anandhan et al., 2022). This evidence concerns the gene NFE2L2 and Parkinson disease.